Questo è quello che abbiamo trovato per te
This study examines the Food and Drug Administration’s accelerated approval pathway and whether preapproval initiation was associated with faster conversion to traditional approval or withdrawal for drugs with nononcology indications.
The US Food and Drug Administration (FDA) has approved the first oral treatment for anemia caused by chronic kidney disease.
La terapia cellulare per il trattamento del glioblastoma multiforme, tumore cerebrale molto aggressivo, rappresenta un cambio di paradigma nell’approccio a una malattia che a oggi non ha una cura
This quality improvement study identifies adverse events for inferior vena cava filters and reports changes in adverse event reporting and estimated insertions between 2016 and 2020 in the US.
The US Food and Drug Administration (FDA) has announced proposed changes in its recommendations governing blood donor eligibility to reduce the risk of transfusion-transmitted HIV. The proposed guidance assesses risk using gender-inclusive, individual questionnaires rather than using broad time-based deferrals.
E’ un tampone nasale, risultati in 30 minuti
New England Journal of Medicine, Ahead of Print.
In sviluppo per tipo episodico,piattaforma e app contro attacchi
Autore/Fonte: INCOG
A treatment that may moderately slow mild cognitive decline and reduce amyloid-β plaques in patients with early Alzheimer disease gained accelerated approval from the US Food and Drug Administration (FDA). Lecanemab-irmb, marketed as Leqembi by Eisai and Biogen, is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer disease.
Autore/Fonte: Canadian Stroke Best Practice
In stato avanzato o metastatico. Prima cura per questa mutazione
Sigot, l’obiettivo è assicurare cure di qualità
Sigot, l’obiettivo è assicurare cure di qualità
iStock.com/andresr
This cross-sectional study evaluates the frequency of new devices receiving US Food and Drug Administration approval through its 510(k) pathway based on predicate devices that had been subject to a Class 1 recall.
